BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Express Pharma - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.expresspharma.in
X-WR-CALDESC:Events for Express Pharma
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20210826T110000
DTEND;TZID=Asia/Kolkata:20210826T123000
DTSTAMP:20260610T052152
CREATED:20210816T054723Z
LAST-MODIFIED:20210816T054723Z
UID:431489-1629975600-1629981000@www.expresspharma.in
SUMMARY:Addressing sterile filter validation challenges of complex fluids | 26th August 2021
DESCRIPTION:Register Now \n\nAs biopharma processes have become increasingly sophisticated\, so have the requirements for performing process-specific bacterial retention studies. \nPall has communicated extensively in recent years on new challenges surrounding the sterile filtration of so-called\, ‘high-risk fluids’. Occurrences of failed bacterial retention studies (i.e. penetration of bacteria through the sterilizing grade filter when tested under the process conditions) are very rare. However\, when penetration has been observed\, Pall has reported that low surface tension fluids\, specifically surfactant solutions\, liposomes\, lipids\, emulsions and lipid-like solutions pose the greatest risk of allowing bacterial penetration through 0.2 µm rated\, sterilizing grade filters. \nTo understand and address the new challenges associated with the sterile filtration validation of high-risk fluids\, Express Pharma in association with Pall Corporation is organizing a webinar with the latest insights from industry experts on the following topics: \n1) Sterile filter validation of complex fluids using QbD approach (Sterility Optimization through the Assessment of Risk – SOAR program)\n2) Re-validation of sterile filtration with reference to PDA TR 26: Addressing process/product changes \nWhy Attend?\n+ Understand how sterile filter validation tests are performed\n+ Analyse how to mitigate product & process risks and maximize sterility assurance through Quality by Design\n+ Get insights on risk analysis on the re-use of filters & decision-making in tests to be carried out\n+ Hear how Pall labs are equipped to handle controlled/cytotoxic drug substances \nSpeakers:\n+ Sudhakar Nagaraj\, Principal Scientist: SLS – Global Regulatory and Validation Consulting Group\, Pall Corporation\n+ Wayne Lee\, Ph.D.\, MBA\, Senior Director\, Global Validation Services and Laboratory Operations\, Pall Corporation\n+ Anand G Ibrahimpur\, Senior Manager – APAC ROA\, Global Validation Services and Laboratory Operations\, Pall Corporation
URL:https://www.expresspharma.in/event/addressing-sterile-filter-validation-challenges-of-complex-fluids-26th-august-2021/
LOCATION:Live Webinar
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2021/08/16111654/EP_Pall_Corp_26th_Aug_2021_Event_Page.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20210825T150000
DTEND;TZID=Asia/Kolkata:20210825T163000
DTSTAMP:20260610T052152
CREATED:20210818T094538Z
LAST-MODIFIED:20210818T120251Z
UID:431568-1629903600-1629909000@www.expresspharma.in
SUMMARY:Next Generation Cell Factories: From Designer Cells to Optimized Processes | 25th August 2021
DESCRIPTION:Register Now \n\nThrough the past few decades\, delivering on the promise of biotechnology and developing cell factories has been understood to be much more than developing a strain in the laboratory\, optimizing process conditions or working on a scale up design.The quality of science ultimately determines a significant portion of the economic value of most bio-based enterprises. Bioprocess platforms designed at the intersections of synthetic biology and systems biology allow one to transcend the realms of basic science into industry.In this context\, automation and Intelligent microbioreactors play a huge role in the biodesign of both pathways and processes. \nThe panel discussion “Making the Unpredictable Predictable: Intelligent Microbioreactors in Biodesign of Pathways and Processes” is born out of the need to present insights and discuss the importance of individual aspects in bioprocess development. Eventually building up to be being more than sum of its parts\, the integration of these upstream and downstream components potentially allow us to holistically deliver on the promise of an emergent efficient and optimal bioprocess. The unique perspectives brought in by each one of you with your expertise\, would potentially highlight methods to make the inevitably unpredictable bioprocess design more predictable and highlight the promise and potential of bioprocess design platforms. \nThe webinar will also showcase the RoboLector(TM) platform as an intelligent microbioreactor designed to build next generation cell factories. \nPanelists:\n+ Dr. Vidhya Rangaswamy\, Vice President\, Reliance Industries\n+ Dr. Rishi Jain\, Assistant Director – Process Research\, Lupin\n+ Dr. Sanjay Nene\, CEO\, Innovation Biologicals and Adjunct Professor in Biochemical Engineering\, AICTE\n+ Prof. KJ Mukherjee\, Department of Biochemical Engineering and Biotechnology\, IIT Delhi\n+ Dr. Rahul Bhambure\, Senior Scientist\, National Chemical Laboratory\n+ Jagadish Bennale\, Business Development Manager\, Beckman Coulter Life Sciences (Danaher Corporation) \nModerator:\n+ Dr. Anu Raghunathan\, Senior Principal Scientist\, Chemical Engineering Division\, CSIR-National Chemical Laboratory
URL:https://www.expresspharma.in/event/next-generation-cell-factories-from-designer-cells-to-optimized-processes-25th-august-2021/
LOCATION:Live Webinar
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2021/08/18173346/EP_Beckman_Coulter_LS_25th_Aug_2021_Event_Page.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20210818T153000
DTEND;TZID=Asia/Kolkata:20210818T170000
DTSTAMP:20260610T052152
CREATED:20210804T084452Z
LAST-MODIFIED:20210812T135756Z
UID:431220-1629300600-1629306000@www.expresspharma.in
SUMMARY:Industry Knowledge eXchange: Redefining Job Roles – Employee Enablement for Digital Adoption in Pharma Industry | 18th August 2021
DESCRIPTION:Register Now \n\nOn the strength of its manufacturing capabilities\, the Pharmaceutical Industry in India is expected to grow significantly this decade. Competition is expected to emerge from geographies that are able to provide low-cost labour. The choice of manufacturing location will be determined by the availability of skilled workforce\, overall efficiency\, embedded compliance and rapid scalability to meet demand. \nRaising workforce skill levels that is commensurate to the demand of manufacturing growth can only be enabled through employee engagement & enterprise-ready learning management systems. Rapid automation is helping remote works stay productive. Technology that can eliminate redundant processes\, enforce compliance and continue to enhance productivity. Ability to run fungible plants and scale manufacturing capacity to address demand will be differentiators. Utilizing technology to build Competitive Compliance would be the hall-mark of the best-run life-sciences companies. \nThe adoption of technology in the pharmaceutical industry needs to improve significantly. Users are not sufficiently enabled to adopt digital tools\, benefit from automation and make data-enabled decisions. In this session\, we will examine what it takes to empower the user in the post-pandemic world where the pharma industry is under the spotlight. Specifically\, we will examine the role of technology in de-imagining business functions such as manufacturing\, QA/ QC\, product development & tech. transfer. The foundational and differentiating role of HR and IT will also be covered as we discuss the following questions: \n+ How can technology help your function – what is basic\, what is a differentiator and what can set you apart?\n+ How equipped is your staff to adopt such technology? Can you talk about the maturity levels across the spectrum?\n+ What are initiatives you are currently working on and where do you see the gaps? \nSpeaker:\n+ Rajesh Kuppuswamy\, Ph.D.\, Life Sciences and Health Care Industry Advisor\, SAP India \nPanelists:\n+ Sudakshina Ghosh\, Industry Business Architect\, Team Lead\, Industry & Customer Advisory Practice\, SAP India\n+ Dr Rajesh Kumar Singh\, Associate Director\, Gennova Biopharmaceuticals\n+ Antony Prashant\, Partner\, Deloitte\n+ Rajendra Chunodkar\, President\, Manufacturing Operations\, Lupin Limited\n+ Avdhut Parab\, Global CIO\, Wockhardt\n+ Namrata Gill Tyagi\, Vice-President\, HR\, Dr. Reddy’s Laboratories\n+ Atul Shastri\, Associate President – Operations\, Aurobindo Pharma \nModerator:\n+ Viveka Roychowdhury\, Editor\, Express Pharma & Express Healthcare
URL:https://www.expresspharma.in/event/industry-knowledge-exchange-redefining-job-roles-employee-enablement-for-digital-adoption-in-pharma-industry-18th-august-2021/
LOCATION:Live Webinar
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2021/08/04133701/EP_SAP_IPA_18th_AUG_2021_Event_Page.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20210817T150000
DTEND;TZID=Asia/Kolkata:20210817T170000
DTSTAMP:20260610T052152
CREATED:20210805T100809Z
LAST-MODIFIED:20210805T103025Z
UID:431271-1629212400-1629219600@www.expresspharma.in
SUMMARY:Accelerating the Process Scale Up - Get it first time right | 17th August 2021
DESCRIPTION:Register Now \n\nWith growing competition\, pharma manufacturers must gear up to build a competitive advantage to retain their market leadership. Computer Modelling and Simulation (CM&S) provides much-needed leverage to scale up production as they move from small pilot studies to progressively larger clinical trials\, then finally into large-scale production of drugs. \nPharma manufacturing systems are highly variable with each system having different levels of interdependence and variability. Simulation helps untangle the chaos and bring out data-backed solutions. \nAs per industry studies\, some major areas where simulation aids pharma companies are:\n– Improved Manufacturing Process Efficiency: 4X reduction in product cost; 9X reduction in development cost\n– Improving Fidelity of Pharma Products\n– Reduce Time-To-Market: 2.5X reduction in the number of change orders which eventually leads to 67% improvement in new product introduction rate\n– By enabling a confluence of industry leaders and simulation experts\, this event will bring out various simulation led strategies aimed at reducing cost\, accurately modelling and understanding process complexities while maintaining product differentiation and improving time to market of drugs. \nKey Discussion Points:\n+ Importance of Innovation in Pharma Manufacturing\n+ Key Challenges Encountered by Pharma Manufacturing\n+ Reducing Time-to-Market in bringing New Vaccine/Drug to the Patient\n+ Making Drugs/Vaccines more Affordable for Indian Population\n+ Maximizing patient safety during Vaccine/Drug Roll-out \nSpeakers:\n+ Birendra Kumar David\, Director\, Dr Reddy’s Laboratories\n+ Thierry Marchal\, Program Director for Healthcare Solutions\, Ansys\n+ Hemant Punekar\, Healthcare Expert- India\, Ansys
URL:https://www.expresspharma.in/event/accelerating-the-process-scale-up-get-it-first-time-right-17th-august-2021/
LOCATION:Live Event
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2021/08/05153856/EP_Ansys_17th_August_2021_Event_Page.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20210715T150000
DTEND;TZID=Asia/Kolkata:20210715T163000
DTSTAMP:20260610T052152
CREATED:20210625T160743Z
LAST-MODIFIED:20210706T115555Z
UID:430432-1626361200-1626366600@www.expresspharma.in
SUMMARY:AccelTRA® Components Program: Ensuring Quality\, Speed and Simplicity in Generics Pharma Packaging | 15th July 2021
DESCRIPTION:Register Now \n\nWith significantly higher quality expectations from regulators\, and the need to ensure quality and patient safety\, fast commercialisation of a new generic drug product can be a challenge. West understands this requirement and has developed a program that will help address customers’ needs with Quality\, Speed and Simplicity. \nWest’s AccelTRA® Elastomer Components Program is a single next-generation formulation for stoppers and plungers that helps generics manufacturers meet increasing quality standards\, ensure fast response to market volatility\, and move product to market quickly. \nWest has launched two line extensions of its AccelTRA® components program\, AccelTRA RTS/RTU\, which are designed specifically for customers manufacturing in or exporting to non-North American markets to help meet either their premium domestic market needs or export needs to Europe\, Asia Pacific\, and elsewhere. \nTo know more\, Express Pharma\, in collaboration with West Pharmaceutical Services\, invites you to a presentation followed by a panel discussion on “How COVID has changed the generic pharma market – Changing trends and innovations in generic packaging” \nWhy Attend:\n+ Learn how to standardize the “One” Elastomer offering to reduce overall stopper SKUs and inventory costs\n+ Get insights from leading market players on West’s AccelTRA® Components Program that help generic customers get their products to desired markets quickly\n+ Understand how optimized lead times help speed products to market quickly \nSpeakers:\n+ Milagro E. Lopez\, Director\, Segment Marketing\, Generics\, West Pharmaceutical Services Ltd\n+ Darshana Chavan\, Technical Account Specialist\, West Pharmaceutical Packaging India Pvt Ltd \nPanelists:\n+ Dr Alagumurugan Alagarswamy\, Director – Injectables/NDDS\, Cipla\n+ Tridip Mazumder\, Associate Director Packaging Development\, Dr Reddy’s Laboratories\n+ Dipesh Thawani\, Deputy General Manager-Packaging Development (PTC)\, Cadila Healthcare\n+ Kwang Kok Li\, Manager for TCS\, Generics Market and AP\, West Pharmaceutical Services
URL:https://www.expresspharma.in/event/acceltra-components-program-ensuring-quality-speed-and-simplicity-in-generics-pharma-packaging-15th-july-2021/
LOCATION:Live Webinar
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2021/06/02104832/EP_WestPharma_15th_July_2021_EventPage_Revised.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20210625T153000
DTEND;TZID=Asia/Kolkata:20210625T170000
DTSTAMP:20260610T052152
CREATED:20210618T074512Z
LAST-MODIFIED:20210623T114744Z
UID:430272-1624635000-1624640400@www.expresspharma.in
SUMMARY:Foundation Excellence – Network and Spend Optimization | 25th June 2021
DESCRIPTION:Register Now \n\nAs India struggles to cope with the second wave of the COVID-19 pandemic\, the focus shifts from discovering what works to delivering what works. \nFrom the challenges of procuring active ingredients and manufacturing equipment from across the globe\, to scaling up the process in line with regulatory compliances and then tracking the products thought the supply chain as they move from factory gate to patient\, pharma companies are ramping up their operational processes. \nThe opportunity is to build a resilient procurement cycle\, which is responsive to emerging diseases beyond the pandemic as well as cost-efficient and focused on spend optimization. \nOpportunities lie in reworking procurement strategies\, using digital tools to track spends\, consider alternative suppliers and revamp supply chains. \nIn this session\, on Foundation Excellence – Network and Spend Optimization we have a select panel of experts discussing the challenges & opportunities for life-sciences organizations\, possible solutions and what should businesses be prepared to become resilient in the next normal \nPanel discussion: Demystifying Procurement for Indian Pharma Organizations: Opportunities\, Challenges and the Way Forward\n+ Talk points for the expert panel discussion:\n+ Uncertainty of supply and demand\n+ Adoption of new regulations\n+ Shift in collaboration across the eco-system \nWhy attend?\n+ Pinpoint the uncertainties of supply and demand\n+ Understand how new regulations will impact your supply chain\n+ Explore possible solutions to become resilient in the next normal \nSpeakers:\n+ Rajesh Kuppuswamy\, Ph.D.\, Life Sciences and Health Care Industry Advisor\, SAP\n+ S G Belapure\, Senior Technical Advisor\, Indian Pharmaceutical Alliances\n+ Debashis Majumder\, Director\, SAP Intelligent Spend Management\, India \nPanelists:\n+ Dr. Mahesh Bhalgat\, Chief Operating Officer\, Syngene International\n+ Dr. Madhu Talla\, Sr. Vice President\, Global Procurement\, Ajanta Pharma Ltd\n+ Sachin Ghosalkar\, Sr. Vice President – Operations\, Indoco Remedies\n+ Anurag Sharma\, Partner\, Consulting – Technology\, Deloitte Touche Tohmatsu India LLP\n+ Debashis Majumder\, Director\, SAP Intelligent Spend Management\, India \nModerator:\n+ Viveka Roychowdhury\, Editor\, Express Pharma & Express Healthcare
URL:https://www.expresspharma.in/event/foundation-excellence-network-and-spend-optimization-25th-june-2021/
LOCATION:Live Event
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2021/06/18131132/EP_SAP_IPA_25thJune2021_EventPage.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20210428T150000
DTEND;TZID=Asia/Kolkata:20210428T163000
DTSTAMP:20260610T052152
CREATED:20210401T110719Z
LAST-MODIFIED:20210401T110719Z
UID:428579-1619622000-1619627400@www.expresspharma.in
SUMMARY:Partnering with Pharma to Transform Drug Delivery | 28th April 2021
DESCRIPTION:Register Now \n\nPhillips-Medisize is a global leader in the design\, development\, and manufacturing of drug delivery devices (e.g. pen injectors; auto-injectors; wearable devices; smart\, connected devices)\, with extensive experience partnering with Pharmaceutical and Biotech companies to deliver injectable and diagnostic portfolios to a global market. Using a unique strategy of integrated product development and manufacturing\, Phillips-Medisize has helped customers in both the Pharmaceutical and Biotech industry deliver complex technologies to end-users\, with both reduced time to market and product launch risk. \nThis approach has allowed Phillips-Medisize\, as a partner to these industries\, to bring cutting-edge technologies to many leading companies delivering injectable and biotechnology platforms to the market. We will present case studies on how our experiences\, technologies\, and services have helped global players rapidly commercialize drug delivery solutions\, with superior product quality and lower total cost of ownership. \nWhat You Will Learn?\n+ How pharmaceutical companies can create a clear path to global success with more affordable\, convenient\, and sustainable injection devices.\n+ Partnership options of ‘Platform’\, ‘Technology Accelerators’ and ‘Custom Design’.\n+ Global manufacturing and drug handling support for improving cost and time to market.\n+ Local support through our Global Innovation and Development (GID) centre in Bangalore (India). \nWho Should Attend?\n+ Device Development Leaders\n+ Packaging Development Leaders\n+ Business Development Leaders\n+ Formulation Development Heads\n+ Marketing Heads\n+ Sourcing Leaders \nSpeakers:\n+ Bill Welch\, Chief Technology Officer\, Phillips-Medisize\n+ Vivek Malhotra\, Director-Sales\, Asia\, Phillips-Medisize
URL:https://www.expresspharma.in/event/partnering-with-pharma-to-transform-drug-delivery-28th-april-2021/
LOCATION:Live Webinar
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2021/04/01162946/EP_PhilipsMedisize_28thApril2021_EvPage.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20210420T100000
DTEND;TZID=Asia/Kolkata:20210420T183000
DTSTAMP:20260610T052152
CREATED:20210303T084920Z
LAST-MODIFIED:20210417T084832Z
UID:427947-1618912800-1618943400@www.expresspharma.in
SUMMARY:PPL Conclave 2021 | 20th April 2021
DESCRIPTION:Register Now \n\nThe COVID-19 crisis is tantamount to a trial by fire for India Pharma Inc. It has had to adapt\, innovate and transform at a pace unprecedented to step up and meet the world’s huge expectations from the “Pharmacy of the World”. \nAnd\, the packaging is playing a crucial role in making the industry stronger and more resilient in the battle against the coronavirus pandemic. Now\, with the roll-out of COVID-19 vaccines underway\, its role has been amplified manifold. After all\, it shares the responsibility of ensuring the safety and efficacy of vaccines\, as well as other medicines and healthcare supplies until they reach those who need them the most. \nKey Topics\n+ Ending the pandemic: How can packaging help?\n+ Packaging megatrends post-COVID-19\n+ The vaccine effect on packaging\n+ A regulatory rehaul: Is it on the cards for pharma packaging & labelling?\n+ Strategies to speed up serialisation\n+ Gauging consumer sentiment: Key for disruption and differentiation\n+ E-commerce and its impact on pharma packaging & labelling\n+ Emergent risks in pharma packaging and mitigation strategies\n+ Evolving role of packaging in pharma supply chain risk management\n+ COVID-19 impact on packaging design and materials\n+ The return of plastics: Whys and wherefores\n+ Sustainability agendas: Can they survive the pandemic?\n+ Antimicrobial and antiviral: New buzzwords in packaging\n+ Smart packaging: Why it is no longer a choice \nWho Will Attend?\n> VP/Director/Head/GM Packaging\n> R&D Packaging Heads\n> Supply Chain Heads\n> Packaging Development Managers\n> Packging Technologists\n> Quality Assurance Professionals \nFor more details\, visit ppl.expresspharma.in
URL:https://www.expresspharma.in/event/ppl-conclave-2021-20th-april-2021/
LOCATION:Virtual Conference
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2021/03/17141852/PPLC_2021_20Apr_EvPage.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20210304T150000
DTEND;TZID=Asia/Kolkata:20210304T160000
DTSTAMP:20260610T052152
CREATED:20210212T131343Z
LAST-MODIFIED:20210212T131443Z
UID:427597-1614870000-1614873600@www.expresspharma.in
SUMMARY:GMP Cleanroom Routine Environmental Monitoring & Therapeutic Vaccine Final Product Testing | 4th March 2021
DESCRIPTION:Register Now \n\nGMP Cleanroom Routine Environmental Monitoring: Learn from the British Standards expert to the ISO Committee for ISO 14644-1:2015 about the GMPs and WHO rules for Cleanroom Classification and Routine Monitoring and how the new MET ONE 3400+ from Beckman Coulter can help with Data Integrity issues of Routine Environmental Monitoring \nTherapeutic Vaccine Final Product Testing: Learn about the challenges of testing therapeutic vaccines to USP<787> and how the HIAC 9703+ from Beckman Coulter can help overcome these challenges \nWhy Attend:\n+ Learn about the GMPs and WHO rules for cleanrooms and the ISO 14644-1:2015 standard.\n+ Understand the difference between cleanroom Classification and Routine Monitoring.\n+ Learn how the new MET ONE 3400+ from Beckman Coulter can help with Data Integrity issues of Routine Environmental Monitoring programs\n+ Understand which types of vaccines can use the USP<787> test for product release\n+ Learn how the HIAC 9703+ from Beckman Coulter can help overcome the challenges of using USP<787> \nSpeaker:\nTony Harrison\, Senior Manager\, Beckman Coulter\n(Former UK expert to ISO Committee for ISO 14644-1:2015)
URL:https://www.expresspharma.in/event/gmp-cleanroom-routine-environmental-monitoring-therapeutic-vaccine-final-product-testing-4th-march-2021/
LOCATION:Live Webinar
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2021/02/12184003/Beckman_Coulter_-4thMar2021_UpEventPage.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20210129T150000
DTEND;TZID=Asia/Kolkata:20210129T163000
DTSTAMP:20260610T052152
CREATED:20201221T124952Z
LAST-MODIFIED:20210113T050651Z
UID:426343-1611932400-1611937800@www.expresspharma.in
SUMMARY:The Reproducibility of Flow Cytometry data – aspects of standardization and validation in Clinical flow cytometry | 29th January 2021
DESCRIPTION:Register Now \n\nFrom a Diagnostic Laboratory perspective it is imperative to provide Clinicians with reliable data for patient management. From a patient and regulatory perspective\, the reported results should be consistent and statistically accurate. Reliable data depends on robust validation protocols and precise Instrument Standardization procedures verified by the end user laboratory on an ongoing basis. \nCome join us for a webinar – ‘The Reproducibility of Flow Cytometry data – aspects of standardization and validation in Clinical flow cytometry’ on followed by an expert panel discussion session on Best Practices in Instrument Setup and Standardization \nWhy Attend:\n+ Learn about Hematopathology and Flowcytometry Assay Validation\n+ Learn about Audit compliance\n+ Importance of using different levels of Controls\n+ Record Management and Data traceability\n+ Addressing Non Conformances \nSpeaker:\nDr Mathias Streitz\, Charité – Universitätsmedizin\, Berlin
URL:https://www.expresspharma.in/event/the-reproducibility-of-flow-cytometry-data-aspects-of-standardization-and-validation-in-clinical-flow-cytometry-29th-january-2021/
LOCATION:Live Webinar
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2020/12/13103700/EP_EH_BC_29Jan2021_EvPage.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20201105T150000
DTEND;TZID=Asia/Kolkata:20201105T160000
DTSTAMP:20260610T052152
CREATED:20201006T121132Z
LAST-MODIFIED:20201028T065922Z
UID:424516-1604588400-1604592000@www.expresspharma.in
SUMMARY:Introducing Smart Autoinjector: Changing the paradigm of usability\, cost & size | 5th November 2020
DESCRIPTION:Register Now \n\nAbout Phillips-Medisize :\nPhillips-Medisize\, LLC\, a Molex company\, is an end-to-end provider of innovation\, development and manufacturing solutions to the pharmaceutical\, diagnostics and medical device market segments. Backed by the combined global resources of Molex and its parent company Koch Industries\, Phillips-Medisize’s core advantage is the knowledge of its people to integrate design\, molding\, electronics and automation\, providing innovative\, high-quality manufacturing solutions. \nDescription :\nFor the past two decades\, single-use disposable autoinjectors have become the predominant drug delivery device to treat immunosuppressive and inflammatory diseases\, and a range of other health conditions. Autoinjectors have evolved to become more compact\, reliable\, and easy to use; however\, these devices also possess certain suboptimal characteristics associated with single-use products. New innovations can now overcome the challenges of traditional disposable autoinjector technology\, while providing a proven platform for pharmaceutical companies. \nJoin this webinar and learn: \n\nWhy disposable\, single-use autoinjectors\, introduced in the early 2000s\, can no longer satisfy today’s requirements to reduce space\, storage\, and waste\nThe growing demand for drug delivery device connectivity to improve patient adherence\, care team collaboration\, and health outcomes\nHow pharmaceutical companies can create a clear path to low-cost connectivity with more affordable\, convenient\, and sustainable injection devices\nExamples of smart\, reusable\, autoinjectors that work with mobile apps to track and transmit digital data from patients to physicians\nKey considerations when embracing a connected health platform for biologic and injectable drugs\n\nSpeakers: \n\nKevin Deane\, Vice President – Front-End Innovation and Connected Health Phillips-Medisize\nVivek Malhotra\, Director Sales\, Asia Phillips-Medisize
URL:https://www.expresspharma.in/event/introducing-smart-autoinjector-changing-the-paradigm-of-usability-cost-size-5th-november-2020/
LOCATION:Live Webinar
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2020/10/06173418/Philips-Medisize_5thNov_EvPage.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20201022T150000
DTEND;TZID=Asia/Kolkata:20201022T160000
DTSTAMP:20260610T052152
CREATED:20200924T175709Z
LAST-MODIFIED:20201021T083446Z
UID:424200-1603378800-1603382400@www.expresspharma.in
SUMMARY:GMP Cleanroom Routine Environmental Monitoring & 21CFR part 11 Data Integrity | 22nd October 2020
DESCRIPTION:Register Now \n\nLearn from the UK ISO expert to the ISO Committee for ISO 14644-1:2015 about the GMPs and WHO rules for cleanrooms and the ISO 14644-1:2015 standard. See how these standards influence GMP Cleanroom Classification and Routine Monitoring. Explore the Data Integrity Challenges for Routine Monitoring and learn how the Unity software from Beckman Coulter can automate routine monitoring to reduce human error and improve Data Integrity. \nWhy Attend: \n\nLearn about the GMPs and WHO rules for cleanrooms and the ISO 14644-1:2015 standard.\nUnderstand the difference between cleanroom Classification and Routine Monitoring.\nUnderstand the causes of Data Integrity Challenges in Routine Monitoring programs\nLearn how the Unity software from Beckman Coulter can automate routine monitoring to reduce human error and improve Data integrity.\nExplore The New Portable Particle Counter MET ONE 3400+\n\nSpeaker: \n\nTony Harrison\, Senior Manager\, Beckman Coulter\, Former UK expert to ISO Committee for ISO 14644-1:2015
URL:https://www.expresspharma.in/event/gmp-cleanroom-routine-environmental-monitoring-21cfr-part-11-data-integrity-22nd-october-2020/
LOCATION:Live Webinar
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2020/09/05131218/EP_BeckmanCoulter_22Oct_GMP_Event_Page.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20200924T150000
DTEND;TZID=Asia/Kolkata:20200924T160000
DTSTAMP:20260610T052152
CREATED:20200916T101455Z
LAST-MODIFIED:20200917T054109Z
UID:423968-1600959600-1600963200@www.expresspharma.in
SUMMARY:Smart Pharma Packaging Technologies | 24th September 2020
DESCRIPTION:Register Now \n\nEnabling IIOT solutions for Smart Pharma Packaging & Serialisation \nThe COVID-19 crisis is tantamount to a trial by fire for India Pharma Inc. And packaging has a crucial role in making the industry stronger and more resilient in the battle against the coronavirus pandemic. After all\, it shares the responsibility of ensuring the safety and efficacy of medicines and other healthcare supplies until they reach those who need them the most. \nThe aim of the webinar is to support the pharma packaging fraternity\, spanning technology solution providers as well as end user industry experts\, as we work our way through a fresh set of challenges and opportunities in a rapidly shifting landscape. \nKeynote Speakers: \n\nChakravarthi AVPS\, Global Ambassador\, World Packaging Organisation\nSaravanan Jeyabalan T\, Associate Director – Packaging\, Development\, Biocon\nKaustubh Joshi\, Director – Strategic Customers & Segments\, Schneider Electric
URL:https://www.expresspharma.in/event/smart-pharma-packaging-technologies-24th-september-2020/
LOCATION:Live Webinar
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2020/09/17111121/EP_Schneider_24Sept_EvPg.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20200421T150000
DTEND;TZID=Asia/Kolkata:20200421T160000
DTSTAMP:20260610T052152
CREATED:20200330T153952Z
LAST-MODIFIED:20200406T122802Z
UID:418592-1587481200-1587484800@www.expresspharma.in
SUMMARY:Virtual Bio Pharma Conclave 2020 - Accelerating Biopharma Innovation | 21st April 2020
DESCRIPTION:Register Now \nThe past few decades have seen the successful development of several immunotherapy based approaches for cancer treatment and several more are in the pipeline. Immunotherapy has become a reality based on multiple discoveries and better understanding of the relationship between tumorigenesis and the immune system. Immune suppression and/or development of mechanisms to evade immune surveillance are now considered as key hallmarks for tumorigenesis in many cancers. \nMore recently\, targeted therapies such as monoclonal antibody based checkpoint inhibitors and T cell based therapy such as chimeric antigen receptors (CARs)-T cells have taken center stage. \nAntibody based checkpoint inhibitor therapies act by removal of tumor induced T-cell suppression thereby resulting in T cell activation\, expansion and clearing of tumor cells. Notably\, monoclonal antibodies targeting PD1 and CTLA-4 have been approved by US FDA for treatment of multiple cancers. \nOn the other hand\, in CAR-T cell therapy normal T cells isolated from the patient are genetically engineered ex vivo and reintroduced to target specifically tumor cells. The field of CAR-T cell therapy continues to evolve and holds much promise for cancer treatment. \nOverall\, the above therapies have demonstrated better response rate in multiple cancers and resulted in better remission rates. Additionally efforts are now on to also explore combination treatments. While several challenges do exist and need to be overcome\, the future holds promise. \nIn this webinar\, the two speakers will provide overviews of the recent advancements in the field of cancer immunotherapy and novel CAR-T cell development. They will also focus on how specific technologies have been leveraged to make immunotherapy a reality. \nJoin this webinar to understand: \n\nFlow cytometry in the era of cancer immunotherapy\nNovel CAR-T development – harnessing versatility for solid tumor therapy\n\nSpeakers: Dr. Maloy Ghosh\, CSO\, Zumutor Biologics & Dr. Michael D’silva\, Senior Principal Investigator\, BBRC \nRegister Now
URL:https://www.expresspharma.in/event/virtual-bio-pharma-conclave-2020-accelerating-biopharma-innovation-21st-april-2020/
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2020/03/02145031/Webinar-VBiopharma-EvPage.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20200213T150000
DTEND;TZID=Asia/Kolkata:20200214T130000
DTSTAMP:20260610T052152
CREATED:20200103T070535Z
LAST-MODIFIED:20200103T071057Z
UID:417182-1581606000-1581685200@www.expresspharma.in
SUMMARY:PPL Conclave 2020 | 13-14 February 2020 | Hyderabad
DESCRIPTION:Register Now \nOrganised by Express Pharma\, PPL Conclave 2020 will be held on 13-14 February 2020 at Novotel Airport\, Hyderabad. \nIt is the platform for packaging leaders\, experts and veterans to assemble\, consult and discourse on the current and future trends in the industry\, their growth drivers and the challenges. \nThus\, for the 100+ leading pharma packaging professionals attending the event\, the two-day event will give an opportunity to: \n\nGet updated on the advancements in India’s pharma packaging sector\nDemonstrate your pharma packaging capabilities\nShowcase your innovative packaging solutions\nGain insights from thought leaders of the pharma\, biotech and packaging industries\nAcquire access to solution providers with cutting-edge packaging technologies\nDiscuss the role of packaging in gaining a competitive edge\nNetwork with the Who’s Who of the pharma packaging industry\n\nTopics: \n\nImpact of global trends on Indian pharma packaging industry\nImpact of IoT and AI in pharma packaging\nDriving patient-centricity with intelligent packaging\nRethinking packaging for regulatory compliance\nDose accuracy and efficacy with packaging\nGreen packaging for sustainability and progress\nPharma packaging for competence\, compliance\, and communication\nAdvancements in pharma packaging technology\nSmart packaging and it’s potential\n\nRegister Now \nFor more information\, please contact:\nUsha Sharma: +91 8169199462 | usha.express2@gmail.com\nKetki Jadhav: +91 8928784287 | ketkijadhav125@gmail.com\nAmruta Shinde: +91 9619781515 | amrutaexpress@gmail.com
URL:https://www.expresspharma.in/event/ppl-conclave-2020-13-14-february-2020-hyderabad/
LOCATION:Novotel Hyderabad Airport\, Airport Approach Road\, Hyderabad\, Telangana\, 500409\, India
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2020/01/03123757/ppl2020_eventpg.jpg
ORGANIZER;CN="Express Pharma":MAILTO:rbhatkal@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20191106T190000
DTEND;TZID=Asia/Kolkata:20191106T210000
DTSTAMP:20260610T052152
CREATED:20191011T191147Z
LAST-MODIFIED:20191011T191147Z
UID:415824-1573066800-1573074000@www.expresspharma.in
SUMMARY:Seminar on Empowering Indian Pharma Through IIOT
DESCRIPTION:Register Now \nAs Industry 4.0 plays out across sectors\, IIoT is taking centre stage with its potential to disrupt conventional business models and make equipment\, employees and processes smarter. IIoT also has the potential to elevate the capabilities of the pharma industry\, leading to significant business advantages. \nYet\, every pharma company is at a different stage as it prepares and transitions for an IIoT-driven future. Though the industry has realised the advantages of this game-changing technology\, it has not yet managed to fully leverage its power and capabilities. \nTherefore\, ACG & Express Pharma\, are organising a seminar under the theme\, ‘Empowering Indian Pharma through IIoT’\, for the stakeholders of the pharma industry. It will serve as a platform to examine and evaluate the ways in which IIoT represents a compelling opportunity for the pharma industry to optimise the efficiency and efficacy of its complex and critical operations (for e.g. manufacturing and supply chain management). \nExperts will discuss and share insights on how the use of IIoT in pharma can usher more efficient production and quality control measures\, improve data integrity\, decrease the risk of machinery breakdowns/malfunctions with predictive and preventive maintenance\, help identify and respond to compliance issues instantly and assure precision production with real-time plant-floor visibility. The experts will also analyse how to set up and integrate IIoT in pharma manufacturing facilities. \nJoin us for this knowledge sharing event\, share your insights and help create a roadmap for the industry’s progress. \nDate: 6th November 2019\nVenue: Grand Ballroom\, Hyatt Regency\, Andheri Mumbai\nTime: 07:00 pm – 09:00 pm (Followed by Cocktails & Dinner) \nRSVP: \n\nLakshmipriya Nair: +91 9819839117\, laxmipriyanair@gmail.com\nKetki Shinde: +91 8928784287\, ketkijadhav125@gmail.com\n\nRegister Now
URL:https://www.expresspharma.in/event/seminar-on-empowering-indian-pharma-through-iiot/
LOCATION:Hyatt Regency Mumbai\, Sahar Airport Road\, Ashok Nagar\, Andheri East\, Mumbai\, Maharashtra\, 400099\, India
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2019/10/12003707/acg-evpg-6thnov.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20191018T143000
DTEND;TZID=Asia/Kolkata:20191018T203000
DTSTAMP:20260610T052152
CREATED:20191001T102534Z
LAST-MODIFIED:20191009T032538Z
UID:415665-1571409000-1571430600@www.expresspharma.in
SUMMARY:Hyderabad Pharma Summit
DESCRIPTION:Register Now \nExpress Pharma is coming back to your city! \nPharma companies are focusing on innovative R&D and developing speciality/ targeted therapies. However\, the Indian industry also needs to understand evolving regulatory requirements\, pricing pressures\, competitive business environments to align themselves accordingly. \nTherefore\, Express Pharma\, a leading industry publication from The Indian Express Group\, is organising the first edition of Hyderabad Pharma Summit on October 18\, 2019 at Manasarovar The Fern\, Hyderabad. \nUnder the theme\, ‘Co-creating a smart ecosystem for pharma‘\, experts and veterans of the industry will address critical issues such as: \n\nBuilding sustainable business environments\nAddressing pricing pressures and brand protection\nReducing dependency on API imports\nScaling-up R&D capabilities and securing the supply chain\nCapitalising on Genome Valley 2.0\nTapping untapped markets (for eg; China and Bangladesh)\nBuilding a world-class regulatory system\nNurturing leadership strategies\nAccelerating employment opportunities\nTelangana government’s roadmap for pharma: wish list from industry\n\nIt is time to understand our inherent strengths and create new capabilities to derive a competitive edge and capitalise on the huge growth opportunity in the changing pharma landscape \nCome\, join us for the Hyderabad Pharma Summit 2019! \nFor complete details visit: hyderabadsummit.expresspharma.in/ \nRegister Now \nRSVP: \n\nKetki Jadhav: +91 9619781515/ketkijadhav125@gmail.com\nUsha Sharma: +91 8169199462/usha.express2@gmail.com
URL:https://www.expresspharma.in/event/hyderabad-pharma-summit/
LOCATION:Manasarovar The Fern\, Hyderabad\, Chiraan Fort Club\, U.S. Consulate\, Lane\, Begumpet\, Secunderabad\, Telangana\, 500003\, India
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2019/10/01154852/EVentPage-Post-Size-1200-x-630.jpg
ORGANIZER;CN="Express Pharma":MAILTO:rbhatkal@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20190927T140000
DTEND;TZID=Asia/Kolkata:20190927T170000
DTSTAMP:20260610T052152
CREATED:20190821T084742Z
LAST-MODIFIED:20190830T185514Z
UID:414997-1569592800-1569603600@www.expresspharma.in
SUMMARY:Sikkim Pharma Summit 2019
DESCRIPTION:Building a competitive advantage for growth \nDate: 27th September 2019 \nVenue: Mayfair Resort\, Gangtok \nRegister Now \nExpress Pharma\, a leading publication from The Indian Express Group\, is organising the second edition of Sikkim Pharma Summit 2019. In its second edition\, the day-long event will witness experts congregate to empower Sikkim to sustain its growth story and build the competitive advantage for growth. The event will also comprise a panel discussion ‘In quest of Sikkim’s USP’\, which will focus on identifying the unique opportunities of the state. \nIt will address the following topics: \n\nEncouraging innovation in formulation and R&D\nScaling-up R&D capabilities\nAssuring quality of medicines\nEnabling regulatory compliance\nDeveloping a cross-functional team culture\nTapping the right talent\nBuilding inclusive employee-friendly policies\nBuilding leadership strategies\n\nHere is your chance to meet and greet key opinion leaders of Sikkim’s pharma industry \nWebsite: sikkimpharmasummit.expresspharmaonline.com \nRegister Now \nRSVP: \n\nUsha Sharma: +91 8169199462\, Email: usha.express2@gmail.com\nPrathamesh Talgaonkar: +91 9619471370\, Email: prathamesh.express@gmail.com
URL:https://www.expresspharma.in/event/sikkim-pharma-summit-2019/
LOCATION:Mayfair Resort\, Gangtok
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2019/08/21141433/sikkim-pharma-summit-2019-evpg-web.jpg
ORGANIZER;CN="Express Pharma":MAILTO:rbhatkal@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20190920T103000
DTEND;TZID=Asia/Kolkata:20190920T163000
DTSTAMP:20260610T052152
CREATED:20190819T080514Z
LAST-MODIFIED:20190901T150125Z
UID:414940-1568975400-1568997000@www.expresspharma.in
SUMMARY:AI\, Analytics and Automation: New Realities of Pharma R&D
DESCRIPTION:Date: 20th September 2019 \nVenue: HITEX\, Hyderabad \nRegister Now \nAn ideal platform to drive innovation in pharma R&D! \nMesse Munchen and Express Pharma are collaborating to organise a day-long conference on the theme\, ‘AI\, Analytics and Automation: New realities of pharma R&D’. \nCo-located with the analytica Anacon India and India Lab Expo\, it will be held on September 20\, 2019 at HITEX\, Hyderabad and will be a perfect platform to initiate discussions and drive\ninnovation in pharma R&D\, with a special focus on lab transformation and management. \nIt would witness the R&D leaders and game changers assemble to converse and confer on topics such as: \n\nInnovation through co-oepition: Panacea or a pipe dream?\nPatient-centric R&D: What does it entail?\nRise of R&D Outsourcing\nTrends in lab design\nGood Laboratory Practices: Key to optimising R&D life cycle management\nCognitive technologies: Catalysing R&D productivity\nR&D leadership with AI and predictive analytics\nR&D procurement in pharma\nLab management in the digital age: Balancing innovation and cost\n\nThus\, there is lot in store for the delegates of this one-day conference. \nRSVP: \n\nDarshita Patel: +91 9769323345\, darshita24express@gmail.com\nAlnaaz Rizvi: +91 8080417465\, alnaazindianexpress@gmail.com\n\nRegister Now
URL:https://www.expresspharma.in/event/ai-analytics-and-automation-new-realities-of-pharma-rd/
LOCATION:HITEX\, Hyderabad
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2019/08/19132350/EP-Lab-conference-EventPg.jpg
ORGANIZER;CN="Express Pharma":MAILTO:rbhatkal@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190823
DTEND;VALUE=DATE:20190824
DTSTAMP:20260610T052152
CREATED:20190708T050613Z
LAST-MODIFIED:20190711T080604Z
UID:414007-1566518400-1566604799@www.expresspharma.in
SUMMARY:Goa Pharma Summit 2019
DESCRIPTION:Date: 23 August 2019 | Venue: The Fern Kesarval Hotel & Spa\, Verna Plateau\, Goa \nWebsite: goapharma.expresspharmaonline.com \nRegister Now \nIndia’s pharma exports rose 11 per cent to $19.2 billion in 2018-19\, accounting for about six per cent of the country’s total exports of $331 billion in this fiscal. (Source: Pharmexcil report). An IBEF Report highlights\,”double-digit growth has returned to pharma exports after three years of flat-to-marginal growth’ This could be a sign that recent upheavals notwithstanding\, our pharma sector is slowly regaining its growth momentum. But\, as India Pharma Inc’s aspirations become bolder\, its progress will be underpinned by the ability to sustain performance and move up the value chain. However\, this will require some tough decisions today to capitalise on the potential opportunities in important markets. \nFuelling sustainable\, long-term growth \nTherefore\, the second edition of Goa Pharma Summit\, organised by Express Pharma\, will focus on the theme ‘Capturing growth in a complex landscape’. This year\, experts and veterans of the industry will examine the new global reality and share learnings to customise their strategies and business models for dealing with increasing volatility and complexity in various business environments and fuelling sustainable\, long-term growth. \nMoreover\, it will also look at establishing the role Goa can play in cementing India Pharma Inc’s dominance on the world stage\, as a premier\, export-oriented\, pharma hub in India. The Summit will seek actionable insights to reinvigorate Goa’s pharma sector and leverage its capabilities to turn India into a global supply destination by finding answers to pertinent questions such as: \n\nHow to increase market penetration and sales growth in new markets and market segments?\nHow to optimise resources to maximise competitive advantages?\nWhat are the key imperatives to capitalise Goa’s strengths and build new-age capabilities?\n\nThus\, there is lot in store for the delegates at Goa Pharma Summit 2019. \nPanel Discussion – Bringing glory back to Goa \nIt will cover the following aspects: \n\nOpportunities for Indian Pharma Inc as a global supply destination with Goa as its nucleus\nKey trends in global domestic markets and supply landscape\nBuilding on India’s cost advantage\nInnovation strategies for the next decade\nLeveraging technology to future-proof key processes\nLearning from international best practices\nEmbracing digital for accelerated growth\nExploring strategic alliances to enter newer markets\nBuilding stronger quality systems for improved compliance\nTackling price controls and protectionism\nEvolving regulatory landscape\n\nWHY GOA? \n\nGoa has a well-developed social\, physical and industrial infrastructure and virtual connectivity\, including an an international airport and significant ports.\nAn established base for the pharma industry and an emerging destination for knowledge-based industries such as biotechnology and IT.\nIt is a fully-electrified state with great connectivity through road\, rail\, air and sea\nThe Goa Investment Policy 2014 is creating a conducive business environment and attracting new industries to Goa\n\n\nFOR MORE INFORMATION:\nRajesh Bhatkal\, +919821313017\, Email: rajesh.bhatkal@expressindia.com\, rbhatkal@gmail.com \nFOR SPONSORSHIP & EXHIBITION BOOTH: \nMUMBAI / AHMEDABAD: \n\nNirav Mistry: +919586424033\, Email: nirav.mistry@expressindia.com\nAshish Rampure: +91 9664565092\, Email: ashish.rampuer@expressindia.com\n\nNEW DELHI: \n\nAmbuj Kumar: +919999070900\, Email: ambuj.kumar@expressindia.com\n\nHYDERABAD: \n\nE Mujahid: +919849039936\, Email: e.mujahid@expressindia.com\n\nBENGALURU: \n\nRajesh Bhatkal: +919821313017\, Email: rajesh.bhatkal@expressindia.com\, rbhatkal@gmail.com\n\nKOLKATA: \n\nAjanta Sengupta: +919831182580\, Email: ajanta.sengupta@expressindia.com\,\n\nFOR DELEGATE REGISTRATION\nUsha Sharma: +91 8169199462\, Email: usha.express2@gmail.com\nAmruta Shinde: +91 8080028866\, Email: amrutaexpress@gmail.com\nKetki Shinde: +91 8928784287\, Email: ketkijadhav125@gmail.com \nThe Indian Express (P) Limited\nRegd Office: Express Towers\, Nariman Point\, Mumbai 400 021\, Tel: 022 – 6744 0000 Fax: 022 – 22885831\nCIN – U22120MH2003PLC142983 \nWebsite: goapharma.expresspharmaonline.com \nRegister Now
URL:https://www.expresspharma.in/event/goa-pharma-summit-2019/
LOCATION:The Fern Kesarval Hotel & Spa\, Bus Stand\, Kesarval Gardens\, Edapally - Panvel Hwy\,\, Quelossim\, Goa\, 403710\, India
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresspharma.in/wp-content/uploads/2019/07/08102623/Goa-Pharma-Summit-2019-EvPg.jpg
ORGANIZER;CN="Express Pharma":MAILTO:rbhatkal@gmail.com
END:VEVENT
END:VCALENDAR